These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24290284)

  • 21. RAG1 deficiency may present clinically as selective IgA deficiency.
    Kato T; Crestani E; Kamae C; Honma K; Yokosuka T; Ikegawa T; Nishida N; Kanegane H; Wada T; Yachie A; Ohara O; Morio T; Notarangelo LD; Imai K; Nonoyama S
    J Clin Immunol; 2015 Apr; 35(3):280-8. PubMed ID: 25739914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.
    Villa A; Sobacchi C; Notarangelo LD; Bozzi F; Abinun M; Abrahamsen TG; Arkwright PD; Baniyash M; Brooks EG; Conley ME; Cortes P; Duse M; Fasth A; Filipovich AM; Infante AJ; Jones A; Mazzolari E; Muller SM; Pasic S; Rechavi G; Sacco MG; Santagata S; Schroeder ML; Seger R; Strina D; Ugazio A; Väliaho J; Vihinen M; Vogler LB; Ochs H; Vezzoni P; Friedrich W; Schwarz K
    Blood; 2001 Jan; 97(1):81-8. PubMed ID: 11133745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. More than just SCID--the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2.
    Niehues T; Perez-Becker R; Schuetz C
    Clin Immunol; 2010 May; 135(2):183-92. PubMed ID: 20172764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development.
    Yu X; Almeida JR; Darko S; van der Burg M; DeRavin SS; Malech H; Gennery A; Chinn I; Markert ML; Douek DC; Milner JD
    J Allergy Clin Immunol; 2014 Apr; 133(4):1109-15. PubMed ID: 24406074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
    Wada T; Toma T; Okamoto H; Kasahara Y; Koizumi S; Agematsu K; Kimura H; Shimada A; Hayashi Y; Kato M; Yachie A
    Blood; 2005 Sep; 106(6):2099-101. PubMed ID: 15845893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological assessment of a patient with Omenn syndrome resulting from compound heterozygous mutations in the RAG1 gene.
    Mou W; Yang Z; Wang X; Hei M; Wang Y; Gui J
    Immunogenetics; 2023 Aug; 75(4):385-393. PubMed ID: 37269334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RAG1 reversion mosaicism in a patient with Omenn syndrome.
    Crestani E; Choo S; Frugoni F; Lee YN; Richards S; Smart J; Notarangelo LD
    J Clin Immunol; 2014 Jul; 34(5):551-4. PubMed ID: 24817258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A newly found homozygous mutation in recombination activating gene 1 in a patient with leaky severe combined immunodeficiency disorder.
    Salari F; Zaremehrjardi F; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Seif F; Movahedi M; Nabavi M
    Mol Biol Rep; 2019 Dec; 46(6):6571-6575. PubMed ID: 31520268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying
    Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V
    Front Immunol; 2023; 14():1268620. PubMed ID: 38022635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Clinical and Genetic Spectrum of 82 Patients With
    Sharapova SO; Skomska-Pawliszak M; Rodina YA; Wolska-Kuśnierz B; Dabrowska-Leonik N; Mikołuć B; Pashchenko OE; Pasic S; Freiberger T; Milota T; Formánková R; Szaflarska A; Siedlar M; Avčin T; Markelj G; Ciznar P; Kalwak K; Kołtan S; Jackowska T; Drabko K; Gagro A; Pac M; Naumova E; Kandilarova S; Babol-Pokora K; Varabyou DS; Barendregt BH; Raykina EV; Varlamova TV; Pavlova AV; Grombirikova H; Debeljak M; Mersiyanova IV; Bondarenko AV; Chernyshova LI; Kostyuchenko LV; Guseva MN; Rascon J; Muleviciene A; Preiksaitiene E; Geier CB; Leiss-Piller A; Yamazaki Y; Kawai T; Walter JE; Kondratenko IV; Šedivá A; van der Burg M; Kuzmenko NB; Notarangelo LD; Bernatowska E; Aleinikova OV
    Front Immunol; 2020; 11():900. PubMed ID: 32655540
    [No Abstract]   [Full Text] [Related]  

  • 31. Omenn syndrome: a disorder of Rag1 and Rag2 genes.
    Villa A; Santagata S; Bozzi F; Imberti L; Notarangelo LD
    J Clin Immunol; 1999 Mar; 19(2):87-97. PubMed ID: 10226883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
    Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
    J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypomorphic
    Ott de Bruin LM; Bosticardo M; Barbieri A; Lin SG; Rowe JH; Poliani PL; Ching K; Eriksson D; Landegren N; Kämpe O; Manis JP; Notarangelo LD
    Blood; 2018 Jul; 132(3):281-292. PubMed ID: 29743177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of nonfunctional B-cell receptor rearrangements in a patient with normal B cell numbers despite partial RAG1 deficiency and atypical SCID/Omenn syndrome.
    Ohm-Laursen L; Nielsen C; Fisker N; Lillevang ST; Barington T
    J Clin Immunol; 2008 Sep; 28(5):588-92. PubMed ID: 18592361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly variable clinical phenotypes of hypomorphic RAG1 mutations.
    Avila EM; Uzel G; Hsu A; Milner JD; Turner ML; Pittaluga S; Freeman AF; Holland SM
    Pediatrics; 2010 Nov; 126(5):e1248-52. PubMed ID: 20956421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutatıons and diverse clinical phenotypes in recombinase-activating gene 1 deficiency.
    Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
    Ital J Pediatr; 2012 Mar; 38():8. PubMed ID: 22424479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in understanding RAG deficiencies.
    Gennery A
    F1000Res; 2019; 8():. PubMed ID: 30800289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic RAG1 mutants obstruct V(D)J recombination in vitro and in vivo.
    Furusawa T; Hosoe M; Ohkoshi K; Takahashi S; Kiyokawa N; Fujimoto J; Amemiya H; Suzuki S; Tokunaga T
    Mol Immunol; 2003 May; 39(14):871-8. PubMed ID: 12686503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A RAG1 mutation found in Omenn syndrome causes coding flank hypersensitivity: a novel mechanism for antigen receptor repertoire restriction.
    Wong SY; Lu CP; Roth DB
    J Immunol; 2008 Sep; 181(6):4124-30. PubMed ID: 18768869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches.
    Bosticardo M; Pala F; Notarangelo LD
    Eur J Immunol; 2021 May; 51(5):1028-1038. PubMed ID: 33682138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.